In the highly competitive, new drug development market, biopharma companies face a myriad of challenges—from balancing cost, time, and quality, to delivering the best possible outcome for their trial and their patients.

Oxford MedWell leverages existing global relationships to assist our clients in gaining immediate access to international market. Utilizing Oxford MedWell global team members’ substantial knowledge and experience in industry, academic and medical settings, we offer comprehensive protocol development services.

Our knowledge of patient populations, standards of care, investigator relationships, and reliable clinical supply chain strategy, not only differentiates us from the competition but also result in executable trials with minimal protocol amendments. In addition, our regulatory expertise and understanding of acceptable endpoints increase the probability that our protocols will be accepted by global regulatory agencies. We hold scientific advisory board meetings and efficiently manage all meeting activities.